Lentiviral Haemopoietic Stem/Progenitor Cell Gene Therapy for Treatment of Wiskott-Aldrich Syndrome: Interim Results of a Non-Randomised, Open-Label, Phase 1/2 Clinical Study

The Lancet Haematology - United Kingdom

doi 10.1016/s2352-3026(19)30021-3